• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清和尿液中2-[[(S)-1-乙氧羰基-3-苯基丙基]-L-丙氨酰]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498)及其水解产物的测定

Determination of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) and its hydrolysis product in serum and urine.

作者信息

Hajdú P, Schmidt D, Bomm M, Hack L, Keller A

出版信息

Arzneimittelforschung. 1984;34(10B):1431-5.

PMID:6097270
Abstract

A highly sensitive and specific enzymatic assay for the quantitative determination of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) and its hydrolysis product Hoe 498-diacid in serum and a GLC method for the simultaneous determination of both compounds in urine are described. Both methods involve extraction from the respective biological fluid using disposable C 18 columns. In serum, the enzyme-inhibiting properties of Hoe 498-diacid (Hoe 498 can readily be converted to its hydrolysis product) are utilized for the determination of both compounds concurrently. The serum extract is dissolved in buffer solution and incubated with human serum as angiotensin converting enzyme (peptidyl-dipeptide-hydrolase, EC 3.4.15.1) source and hip-his-leu substrate. The hippuric acid liberated is quantitated by HPLC. The urine extract is treated with diazomethane followed by trifluoroacetic anhydride to convert Hoe 498 and Hoe 498-diacid to their methylester, trifluoroacetyl derivatives, which are then determined simultaneously by GLC using a nitrogen specific detector.

摘要

本文描述了一种高灵敏度和特异性的酶法,用于定量测定血清中的2-[[(S)-1-乙氧羰基-3-苯基丙基]-L-丙氨酰]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498)及其水解产物Hoe 498-二酸,以及一种气相色谱法用于同时测定尿液中的这两种化合物。两种方法均涉及使用一次性C18柱从各自的生物流体中进行萃取。在血清中,利用Hoe 498-二酸的酶抑制特性(Hoe 498可轻易转化为其水解产物)同时测定这两种化合物。将血清提取物溶解于缓冲溶液中,并与人血清作为血管紧张素转换酶(肽基二肽水解酶,EC 3.4.15.1)来源以及马尿酰-组氨酰-亮氨酸底物一起孵育。释放出的马尿酸通过高效液相色谱法定量。尿液提取物先用重氮甲烷处理,然后用三氟乙酸酐处理,将Hoe 498和Hoe 498-二酸转化为它们的甲酯、三氟乙酰衍生物,然后使用氮特异性检测器通过气相色谱法同时测定。

相似文献

1
Determination of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) and its hydrolysis product in serum and urine.血清和尿液中2-[[(S)-1-乙氧羰基-3-苯基丙基]-L-丙氨酰]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498)及其水解产物的测定
Arzneimittelforschung. 1984;34(10B):1431-5.
2
Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.2-[N-[(S)-1-羧基-3-苯基丙基]-L-丙氨酰]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498二酸)对血管紧张素转换酶的抑制作用。与卡托普利和依那普利拉的比较。
Arzneimittelforschung. 1984;34(10B):1406-10.
3
Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Arzneimittelforschung. 1984;34(10B):1399-401.
4
2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor.2-[N-[(S)-1-乙氧羰基-3-苯基丙基]-L-丙氨酰]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498)——一种新型高效的血管紧张素I转换酶抑制剂。
Arzneimittelforschung. 1984;34(10B):1402-6.
5
Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).新型口服活性血管紧张素转换酶抑制剂2-[[(S)-1-乙氧羰基-3-苯基丙基]-L-丙氨酰基]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498)的药理特性
Arzneimittelforschung. 1984;34(10B):1411-6.
6
A radioimmunoassay for the angiotensin converting enzyme inhibitor ramipril and its active metabolite.一种用于检测血管紧张素转换酶抑制剂雷米普利及其活性代谢物的放射免疫分析方法。
Arzneimittelforschung. 1985;35(8):1251-6.
7
Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers.血管紧张素转换酶抑制剂2-[N-[(S)-1-乙氧羰基-3-苯基丙基]-L-丙氨酰]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498)在健康志愿者中的耐受性和药效学
Arzneimittelforschung. 1984;34(10B):1448-51.
8
Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).新型非巯基转化酶抑制剂2-[N-[(S)-1-乙氧羰基-3-苯基丙基]-L-丙氨酰]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498)的心血管及抗高血压活性
Arzneimittelforschung. 1984;34(10B):1417-25.
9
Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension.
Arzneimittelforschung. 1984;34(10B):1452-4.
10
2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats.2-[N-[(S)-1-乙氧羰基-3-苯基丙基]-L-丙氨酰基]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498):对自发性高血压大鼠的降压作用及对组织转化酶活性的持续抑制
Arzneimittelforschung. 1984;34(10B):1426-30.

引用本文的文献

1
Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study.
Eur J Clin Pharmacol. 1993;45(3):241-6. doi: 10.1007/BF00315390.
2
Clinical pharmacokinetics of ramipril.雷米普利的临床药代动力学
Clin Pharmacokinet. 1994 Jan;26(1):7-15. doi: 10.2165/00003088-199426010-00002.
3
Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects.一种新型口服活性血管紧张素转换酶抑制剂(HOE 498)在健康受试者中的药代动力学和药效学。
Eur J Clin Pharmacol. 1984;27(5):577-81. doi: 10.1007/BF00556895.
4
A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.新型非巯基转换酶抑制剂HOE 498对正常男性血压、脉搏率及肾素-血管紧张素-醛固酮系统的剂量反应研究。
Br J Clin Pharmacol. 1985 Jul;20(1):27-35. doi: 10.1111/j.1365-2125.1985.tb02794.x.
5
The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers.转化酶抑制剂HOE 498对正常志愿者肾素-血管紧张素系统的作用。
Naunyn Schmiedebergs Arch Pharmacol. 1985 Mar;329(1):63-9. doi: 10.1007/BF00695194.
6
Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.速尿、血管紧张素转换酶抑制剂、肾多巴胺与前列腺素:正常人的急性相互作用
Br J Clin Pharmacol. 1989 Dec;28(6):683-94. doi: 10.1111/j.1365-2125.1989.tb03561.x.
7
Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.雷米普利。对其药理特性及在心血管疾病中的治疗效果的综述。
Drugs. 1990 Jan;39(1):110-35. doi: 10.2165/00003495-199039010-00009.